In the United States, dietary supplements are regulated as a subcategory of food and therefore are not required to undergo review and approval by the U.S. Food and Drug Administration (FDA). This inadequate regulatory framework has allowed adulterated and mislabeled products to repeatedly enter the market and poses a health threat to the public. In this position paper, the American College of Physicians offers policy recommendations to bolster the FDA's pre- and postmarket regulatory authority for dietary supplements, standardize dietary supplement terminology and data sharing, and implement changes within the health care system to improve care for patients using dietary supplements.

Obstructive sleep apnea (OSA) is a common but frequently undiagnosed condition. Symptoms include loud snoring, nocturnal awakening, and daytime sleepiness. Treating OSA can meaningfully improve symptoms and achieve modest reductions in blood pressure. Although OSA care has traditionally been limited to sleep specialists, technologies are available that allow primary care clinicians to diagnose OSA and initiate treatment. Treatments include positional therapy, weight management, application of external positive airway pressure, mandibular advancement devices, and surgical interventions. Inpatient identification and management of OSA is also feasible and is an evolving area of research and practice.

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Hematology: [Formula: see text].

GIM/FP/GP: [Formula: see text] Pulmonology: [Formula: see text].

GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text].